Making decisions with real-world evidence and COVID-19
The COVID-19 pandemic has triggered intense and widespread action among the biopharma industry and...
Zombie Data: The silent threat to real-world data in life sciences
In the rapidly evolving world of real-world data (RWD) for life sciences and commercial applications, data provenance and data quality serve as unwavering cornerstones for actionable insights. Yet, an unsettling trend has emerged in the form of "...
Beyond COVID-19 with HealthVerity Patient Confidence Index
The coronavirus pandemic continues to be a disruptive force for patients and physicians across the...
Removing gaps in the patient journey with closed payer claims
Patient centricity is top of mind for life sciences companies today. In order to put the patient at...
How healthcare marketing is catching up
Healthcare has the lowest digital ad spend among major industries today. Privacy protection laws...
Putting data to work for value-based agreements
Complex medical treatments like gene and immunotherapies have brought us into a new era of...
CCPA: Connected devices and new privacy regulations
Connected devices are here to stay. The conveniences they offer can make it easy to forget just how...
Countdown to the CCPA: What Financial Services Industry Must Know
By: John Chaisson, Data Privacy & Blockchain,HealthVerity Perhaps no other industry is as heavily...
A new acronym and privacy considerations in the healthcare industry
HIPAA (Health Insurance Portability and Accountability Act) has long been the acronym synonymous...
Indirect measures: False negatives
4 part series [Part 3] ofMatching Accuracy Metrics |Catch up on Part 1 and Part 2, or read Part 4
Indirect Measures: False Positives
4 part series [Part 2] ofMatching Accuracy MetricsContinue readingPart 1,Part 3, and Part 4By:...